Anixa Biosciences, Inc. (ANIX)
2.65
-0.12
(-4.33%)
USD |
NASDAQ |
Mar 20, 16:00
2.93
+0.28
(+10.57%)
After-Hours: 20:00
Anixa Biosciences EPS Diluted (Quarterly) : -0.0772 for Jan. 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Agenus, Inc. | -0.301 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| Arrowhead Pharmaceuticals, Inc. | 0.219 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.585M |
| Total Expenses (Quarterly) | 2.565M |
| Enterprise Value | 73.61M |
| Earnings Yield | -11.88% |
| Normalized Earnings Yield | -11.89 |